An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray.
An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray Compared to Actiq® for the Management of Breakthrough Pain in Chronic Pain Patients.
Sponsor: International Clinical Research Institute
Terminated
Enrollment was more challenging than anticipated.
Other Breakthrough Pain trials with similar outcome
This observational or N/A phase trial investigates Breakthrough Pain and is currently terminated or withdrawn. International Clinical Research Institute leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- International Clinical Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .